High‐dose methylprednisolone in children with acute nonlymphoblastic leukemia

[1]  N. Karadeniz,et al.  Direct morphological evidence of high-dose methylprednisolone-induced maturation of leukemic cells in children with acute nonlymphoblastic leukemia. , 1991, Experimental hematology.

[2]  K. Oshimi,et al.  Successful treatment of refractory anemia with high‐dose methylprednisolone , 1990, American journal of hematology.

[3]  Ş. Ozsoylu,et al.  High-dose methylprednisolone for acute nonlymphoblastic leukemia. , 1989, Experimental hematology.

[4]  G. Irken,et al.  High‐dose methylprednisolone for remission induction in children with acute nonlymphoblastic leukemia , 1989, European journal of haematology.

[5]  T. Olofsson,et al.  Modulation of the production of leukemia associated inhibitor (LAI) and its interaction with granulocyte-macrophage colony-forming cells. , 1987, Experimental hematology.

[6]  Y. Honma,et al.  Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies. , 1987, Cancer research.

[7]  Y. Honma,et al.  Glucocorticoid binding and mechanism of resistance in some clones of mouse myeloid leukemic cells resistant to induction of differentiation by dexamethasone , 1977, Journal of cellular physiology.

[8]  J. Lotem,et al.  Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormones , 1975, International journal of cancer.